184 related articles for article (PubMed ID: 16087866)
1. Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.
Ronai D; Iglesias-Ussel MD; Fan M; Shulman MJ; Scharff MD
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11829-34. PubMed ID: 16087866
[TBL] [Abstract][Full Text] [Related]
2. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
Komori A; Xu Z; Wu X; Zan H; Casali P
Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
[TBL] [Abstract][Full Text] [Related]
3. Recombinase-mediated cassette exchange as a novel method to study somatic hypermutation in Ramos cells.
Baughn LB; Kalis SL; MacCarthy T; Wei L; Fan M; Bergman A; Scharff MD
mBio; 2011; 2(5):. PubMed ID: 21990614
[TBL] [Abstract][Full Text] [Related]
4. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
Yang SY; Fugmann SD; Schatz DG
J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
[TBL] [Abstract][Full Text] [Related]
5. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas.
Martin A; Bardwell PD; Woo CJ; Fan M; Shulman MJ; Scharff MD
Nature; 2002 Feb; 415(6873):802-6. PubMed ID: 11823785
[TBL] [Abstract][Full Text] [Related]
6. Identification of core DNA elements that target somatic hypermutation.
Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG
J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403
[TBL] [Abstract][Full Text] [Related]
7. Attracting AID to targets of somatic hypermutation.
Tanaka A; Shen HM; Ratnam S; Kodgire P; Storb U
J Exp Med; 2010 Feb; 207(2):405-15. PubMed ID: 20100870
[TBL] [Abstract][Full Text] [Related]
8. Comparison of identical and functional Igh alleles reveals a nonessential role for Eμ in somatic hypermutation and class-switch recombination.
Li F; Yan Y; Pieretti J; Feldman DA; Eckhardt LA
J Immunol; 2010 Nov; 185(10):6049-57. PubMed ID: 20937850
[TBL] [Abstract][Full Text] [Related]
9. Why does somatic hypermutation by AID require transcription of its target genes?
Storb U
Adv Immunol; 2014; 122():253-77. PubMed ID: 24507160
[TBL] [Abstract][Full Text] [Related]
10. Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation.
Giusti AM; Manser T
J Exp Med; 1993 Mar; 177(3):797-809. PubMed ID: 8436910
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor binding at Ig enhancers is linked to somatic hypermutation targeting.
Dinesh RK; Barnhill B; Ilanges A; Wu L; Michelson DA; Senigl F; Alinikula J; Shabanowitz J; Hunt DF; Schatz DG
Eur J Immunol; 2020 Mar; 50(3):380-395. PubMed ID: 31821534
[TBL] [Abstract][Full Text] [Related]
12. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
[TBL] [Abstract][Full Text] [Related]
13. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
[TBL] [Abstract][Full Text] [Related]
14. The IgH 3' regulatory region controls somatic hypermutation in germinal center B cells.
Rouaud P; Vincent-Fabert C; Saintamand A; Fiancette R; Marquet M; Robert I; Reina-San-Martin B; Pinaud E; Cogné M; Denizot Y
J Exp Med; 2013 Jul; 210(8):1501-7. PubMed ID: 23825188
[TBL] [Abstract][Full Text] [Related]
15. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
[TBL] [Abstract][Full Text] [Related]
16. The IgH
Martin OA; Thomas M; Marquet M; Bruzeau C; Garot A; Brousse M; Bender S; Carrion C; Choi JE; Vuong BQ; Gearhart PJ; Maul RW; Le Noir S; Pinaud E
Front Immunol; 2023; 14():1030813. PubMed ID: 36865553
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
[TBL] [Abstract][Full Text] [Related]
18. Somatic hypermutation of the AID transgene in B and non-B cells.
Martin A; Scharff MD
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12304-8. PubMed ID: 12202747
[TBL] [Abstract][Full Text] [Related]
19. Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.
Buerstedde JM; Alinikula J; Arakawa H; McDonald JJ; Schatz DG
PLoS Biol; 2014 Apr; 12(4):e1001831. PubMed ID: 24691034
[TBL] [Abstract][Full Text] [Related]
20. A Model of Somatic Hypermutation Targeting in Mice Based on High-Throughput Ig Sequencing Data.
Cui A; Di Niro R; Vander Heiden JA; Briggs AW; Adams K; Gilbert T; O'Connor KC; Vigneault F; Shlomchik MJ; Kleinstein SH
J Immunol; 2016 Nov; 197(9):3566-3574. PubMed ID: 27707999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]